We measured 3-lipoprotein in 232 cord sera by rate nephelometry and compared the results with those obtained by electroimmunoassay.
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We measured 3-lipoprotein in 232 cord sera by rate nephelometry and compared the results with those obtained by electroimmunoassay.
The mean (and mean ± two standarddeviations) was 544(293-1009) mgIL by rate nephelometry and 503 (265-955) mg/L by electroimmunoassay. The between-assay correlation coefficient was 0.891. Between-run coefficients of variation were 3.5-4.4% for nephelometry and 11-14% for electroimmunoassay. Nephelometry was faster, more precise, and less labor intensive than electroimmunoassay. For these reasons, rate nephelometry appears to be a more suitable assay system for mass screening, should detection of familial hypercholesterolemia prove feasible and desirable.
AdditIonal Keyphrases:electroimmunoassay comparedreference interval for cord sera ' calibrator differences Increases in serum cholesterol and 9-lipoprotein are associated with an increased risk of premature coronary heart disease. This is especially true for familial hypercholesterolemia (FHC),' an inherited disorder affecting one in 200 to 500 individuals in the general population (1) . Most individuals affected with FHC are not identified until adulthood, often after the onset of coronary symptoms, even though the onset of lipid pathology was prenatal.
Most affected newborns at risk for FHC by family history appear to be identifiable through low-density Iipoprotein(LDL)-cholesterol determination in cord blood, but such testing has neither the sensitivity nor the specificity required for routine screening of newborns (2) . 9-Lipoprotein quantitation may be a better indicator of coronary heart disease risk than is assay of total cholesterol or LDL-cholesterol (3, 4) , and indeed a recent study identified a group of patients with angiographically defined coronary heart disease who had normal LDL-cholesterol concentrations but increased f3-lipoprotein concentrations (5). Several immunoassays have been developed for measuring fl-lipoprotein in adult sera, including radial immunodiffusion (6, 7), electroimmunoassay (7) (8) (9) (10) , nephelornetry (8, (11) (12) (13) , radioimmunoassay (7, 8, 14, 15) , and enzyme immunoassay (16) . Methods for fl-lipoprotein quantitation in cord blood include radial immunodiffusion (13) and electroimmunoassay (18, 19) , the latter being the more precise but labor intensive, which thus limits sample throughput.
We report here a nephelometric assay for /3-lipoprotein in cord sera, which is rapid and easily automated for mass screening. We have also (11) (12) (13) .
Results

Precision:
High, mid-range, and low ( Twenty-three of the cord serum samples that had been assayed by ICS rate nephelometry and by electroimmunoassay were also quantitated by an established Technicon Automated Immunoprecipitin endpoint nephelometric test routinely used in our laboratory for clinical /3-lipoprotein quantitation in venous samples (12) . The correlation between rate nephelometry and endpoint nephelometry ( Figure 5 ) produced a regression line of y = 1. Table 3 lists and compares the mean 3-lipoprotein concentrations of each category. There were no significant differences between the means from males and females, infants of low and normal birthweight, or infants of early and normal gestational age.
We also examined effects of birthweight and gestational age by plotting each parameter vs fi-lipoprotein concentration and evoking regressional analysis. The correlation coefficients were -0.062 for birthweight and -0.041 for gestational age, indicating that there is no relation between either of these variables and fi-lipoprotein value.
Because we found no significant differences in fi-lipoprotein concentration attributable to sex, birthweight, or gestational age, we combined the results from all samples to establish a normal range for /3-lipoprotemn.
Normal range: Figure 3 illustrates the fi-lipoprotein concentrations for 232 cord sera assayed by rate nephebometry and electromimmunoasaay.
The We Our mean concentration of 544 mg of /3-lipoprotein per liter in cord serum is consistent with most 3-lipoprotein studies to date. Several investigators who have purified and characterized 13-lipoprotein and developed immunoassays for it report that serum from adults contains an average of 700 to 1000 mg of fl-lipoprotein per liter (6-9, 14,15) . Other studies (18, 25) , as well as experience in our own clinical laboratory (13) 
Theoretical and Mathematical Conditions for Use of Linearization Methods for Saturation-Type Radioassay Data
Wliliam Shaw
The algebraic equivalency of nine different methods for the linearization of saturation-type radioassay data was previously demonstrated mathematically to hold under the assumption that the antibody is saturated with ligand. Although complete saturation with antibody never occurs, a good approximation to a saturation condition occurs when the product of the labeled ligand and the affinity constant is 100 or more. The mathematical basis for determining when methods for the linearization of saturation-type radioassay data are valid is derived from a development of the first-order mass action law applied to ligand-antibody reactions.
AddItIonal Keyphrases: added to the assay system, which can be expressed mathematically as:
where p' is the concentration of unlabeled ligand and p4 is the concentration of labeled ligand. The purpose of this publication is to demonstrate mathematically the conditions under which this underlying assumption is true. The appropriate mathematical conditions can be derived from a development of the first-order mass action law applied to the following reaction:
where the rate of the forward reaction equals k1 [P] [Q], the
